600568.SS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 06:29):

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs...

Stats
Šios dienos apimtis	3.82M
Vidutinė apimtis	6.55M
Rinkos kapitalizacija	2.89B
EPS	CNY-0.108 ( 2023-06-30 )
Kita pelno data	( CNY0 ) 2024-05-08
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-8.53
ATR14	CNY0.00400 (0.28%)

Tūris Koreliacija

Ilgas: -0.01 (neutral)

Trumpas: 0.56 (weak)

Signal:(41.707) Neutral

Zhongzhu Healthcare Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Zhongzhu Healthcare Koreliacija - Valiuta/Žaliavos

-0.60
( weak negative )

-0.49
( neutral )

0.00
( neutral )

-0.58
( weak negative )

0.39
( neutral )

Zhongzhu Healthcare Finansinės ataskaitos

Annual	2023
Pajamos:	CNY580.06M
Bruto pelnas:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2023
Pajamos:	CNY580.06M
Bruto pelnas:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2022
Pajamos:	CNY505.97M
Bruto pelnas:	CNY127.46M (25.19 %)
EPS:	CNY-0.400

FY	2021
Pajamos:	CNY581.06M
Bruto pelnas:	CNY166.24M (28.61 %)
EPS:	CNY-0.105

Financial Reports:

No articles found.

Zhongzhu Healthcare

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.